ResultsIQ › Latest results › Nephrocare Health Services Limited
Nephrocare Health Services Limited Q4 FY26 results press release summary
NSE: NEPHROPLUS · BSE: 544647
Results press release of 19 May 2026, summarised by AI from the filing.
₹998.8 cr, up 32.2% YoY, driven by 16.6% treatment volume growth and higher international mix.
Key takeaways
- FY26 revenue ₹998.8 cr, up 32.2% YoY, driven by 16.6% treatment volume growth and higher international mix.
- International mix International revenue contribution rose from 31.8% in FY25 to 41.8% in FY26, lifting revenue per treatment.
- Q4 margin Q4 FY26 adjusted EBITDA margin 20.9% (Q4 FY25: 24.6%, -380 bps).
- FY27 focus Deepening India presence, scaling international businesses and evaluating opportunities in new geographies.
Nephrocare Health Services Limited Q1 FY27 results
As filed: Revenue ₹282 cr, EBITDA ₹63.9 cr, PAT ₹32.0 cr, EBITDA margin 22.7%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹282 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹266 cr, EBITDA ₹53.8 cr, PAT ₹30.4 cr, EBITDA margin 20.2%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹266 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.3% in 30 days (Nifty 500: +3.0%).
- Q3 FY26: Revenue ₹260 cr, EBITDA ₹60.9 cr, PAT ₹32.2 cr, EBITDA margin 23.4%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹260 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +4.5% in 30 days (Nifty 500: −7.8%).
Past price moves after results do not indicate future moves. Not a recommendation.
Nephrocare Health Services Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (12 Aug 2026), Results deck (11 Aug 2026), Results press release (11 Aug 2026)
- Q4 FY26: Earnings call (20 May 2026), Results deck (19 May 2026), Results press release (19 May 2026)
- Q3 FY26: Earnings call (11 Feb 2026), Results deck (10 Feb 2026), Results press release (10 Feb 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.